Covidien introduces Plus Bladeless Trocar line for the minimally invasive surgical market





Covidien, a leading global provider of healthcare products, announced that its Surgical Devices business unit has launched the Versaport(TM) Plus Bladeless Trocar line for the minimally invasive surgical market worldwide.

Covidien, a leading global provider of healthcare products, announced that its Surgical Devices business unit has launched the Versaport(TM) Plus Bladeless Trocar line for the minimally invasive surgical market worldwide.

The Versaport(TM) Plus Bladeless Trocars offer surgeons greater precision and control, low insertion force, a small facial defect and superior port fixation with Covidien's proprietary secure entry technology. When the Versaport(TM) Plus Bladeless Trocar is combined with Step(TM) technology in VersaStep(TM) Plus, Covidien sets the standard for safety in laparoscopic entry and provides medical professionals with a comprehensive line of bladeless access devices.

Scott Flora, President, Surgical Devices, Covidien said, Our innovative Versaport(TM) Plus Bladeless Trocars are the latest example of Covidien's collaboration with customers to offer access solutions that give them the sense of confidence, security and control that they have been asking for. This product launch, when coupled with some of our current technologies, significantly enhances our position in the rapidly growing market for bladeless access devices and trocars.

Versaport(TM) Plus Bladeless Trocars can be used in conventional and advanced laparoscopic procedures in general, bariatric, colon and rectal, gynecological and urological surgery.